Pomyelo 4 mg Capsule

उत्पाद विवरण

Pomyelo 4 mg capsules are a specialized anticancer treatment classified as an immunomodulatory agent, specifically designed to manage multiple myeloma, a challenging type of blood cancer. This medication is particularly beneficial for patients who have already undergone at least two prior therapies, including lenalidomide and a proteasome inhibitor, providing a crucial option for those with advanced disease. Pomyelo works by enhancing the immune system's ability to target and destroy cancer cells, thereby improving the chances of treatment success. However, it's essential to be aware of potential side effects, including fatigue, nausea, and a risk of infections, which may arise due to its immunosuppressive properties. Patients using Pomyelo should be closely monitored by healthcare providers to manage any adverse reactions effectively. It is crucial to follow the prescribed dosage and consult with a healthcare professional regarding any pre-existing conditions or medications, as interactions may occur. By offering a targeted approach to treatment, Pomyelo 4 mg capsules represent a vital option for individuals facing the complexities of multiple myeloma.